Skip to main content
AAN.com

Abstract

Administering the Neuropsychiatric Inventory (NPI), we examined the behavioral symptoms of 22 patients with progressive supranuclear palsy (PSP), 50 patients with Alzheimer's disease, and 40 controls.PSP patients exhibited apathy (91%), disinhibition (36%), dysphoria (18%) and anxiety (18%), but rarely (<9%) irritability, abnormal motor behaviors, or agitation. Apathy in PSP was significantly associated with executive dysfunction. The presence of high apathy and low agitation and anxiety scale scores correctly identified the PSP patients 85% of the time. Evaluating the behavioral abnormalities of patients with neurodegenerative disorders will aid diagnosis and facilitate management.
NEUROLOGY 1996;47: 1184-1189

Get full access to this article

View all available purchase options and get full access to this article.

REFERENCES

1.
Albert ML, Feldman RG, Willis AL. The `subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974;37:121-130.
2.
Cambier J, Masson M, Viader F, Limodin J, Strube A. Frontal syndrome of progressive supranuclear palsy. Rev Neurol (Paris) 1985;141:528-536.
3.
Pillon B, Dubois B, Lhermitte F, Agid Y. Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease. Neurology 1986;36:1179-1185.
4.
Dubois B, Pillon B, Legault F, Agid Y, Lhermitte F. Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease. Arch Neurol 1988;45:1194-1199.
5.
Cummings JL, Benson DF. Psychological dysfunction accompanying subcortical dementias. Annu Rev Med 1988;39:53-61.
6.
Litvan I, Grafman J, Gomez C, Chase T. Memory impairment in patients with progressive supranuclear palsy. Arch Neurol 1989;46:765-767.
7.
Grafman J, Litvan I, Gomez C, Chase TN. Frontal lobe function in progressive supranuclear palsy. Arch Neurol 1990;47:553-558.
8.
Pillon B, Dubois B, Ploska A, Agid Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology 1991;41:634-643.
9.
Johnson R Jr, Litvan I, Grafman J. Progressive supranuclear palsy: altered sensory processing leads to degraded cognition. Neurology 1991;41:1257-1262.
10.
Johnson RJ. Event-related brain potentials. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992;122-154.
11.
Litvan I. Cognitive disturbances in progressive supranuclear palsy. J Neural Transm Suppl 1994;42:69-78.
12.
Blin J, Baron JC, Dubois B, et al. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol 1990;47:747-752.
13.
Grafman J, Litvan I, Stark M. Neuropsychological features of progressive supranuclear palsy. Brain Cogn 1995;28:311-320.
14.
Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival. J Neurol Neurosurg Psychiatry 1996;60:615-620.
15.
Deutsch LH, Bylsma FW, Rovner BW, Steele C, Folstein MF. Psychosis and physical aggression in probable Alzheimer's disease. Am J Psychiatry 1991;148:1159-1163.
16.
Cummings JL, Diaz C, Levy M, Binetti G, Litvan I. Behavioral syndromes in neurodegenerative diseases: frequency and significance. Sem Neuropsychiatry; in press.
17.
Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 1990;147:1049-1051.
18.
Morriss RK, Rovner BW, Folstein MF, German PS. Delusions in newly admitted residents of nursing homes. Am J Psychiatry 1990;147:299-302.
19.
O'Donnell BF, Drachman DA, Barnes HJ, Peterson KE, Swearer JM, Lew RA. Incontinence and troublesome behaviors predict institutionalization in dementia. J Geriatr Psychiatry Neurol 1992;5:45-52.
20.
Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 1993;43:2227-2229.
21.
Goetz CG, Stebbins GT. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology 1995;45:669-671.
22.
Rabins PV, Mace NL, Lucas MJ. The impact of dementia on the family. JAMA 1982;248:333-345.
23.
Sadler JZ, Kurtz NM, Rush AJ. Progressive supranuclear palsy presenting as pseudodementia. Psychosomatics 1984;25:713-714.
24.
Schneider LS, Chui HC. Progressive supranuclear palsy manifesting with depressive features. J Am Geriatr Soc 1986;34:663-665.
25.
Schneider LS, Gleason RP, Chui HC. Progressive supranuclear palsy with agitation: response to trazodone but not to thiothixine or carbamazepine. J Geriatr Psychiatry Neurol 1989;2:109-112.
26.
Trzepacz P, Murcko A, Gillespie M. Progressive supranuclear palsy misdiagnosed as schizophrenia. J Nerv Ment Dis 1985;173:377-378.
27.
Destee A, Gray F, Parent M, et al. Obsessive-compulsive behavior and progressive supranuclear palsy. Rev Neurol (Paris) 1990;146:12-18.
28.
Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996;46:131-135.
29.
Cooper JK, Mungas D, Weiler PG. Relation of cognitive status and abnormal behaviors in Alzheimer's disease. J Am Geriatr Soc 1990;38:867-870.
30.
Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992;4:134-139.
31.
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein PH. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
32.
Rubin EH, Morris JC, Storandt M, Berg L. Behavioral changes in patients with mild senile dementia of the Alzheimer's type. Psychiatry Res 1987;21:55-62.
33.
Petry S, Cummings JL, Hill MA, Shapira J. Personality alterations in dementia of the Alzheimer type. Arch Neurol 1988;45:1187-1190.
34.
Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 1996;46:922-930.
35.
Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015-2019.
36.
Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathological criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97-105.
37.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Press, 1994.
38.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group, Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
39.
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state:" a practical method for grading the mental state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
40.
Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasu TB, eds. Geriatric psychiatry. New York, NY: Grune & Stratton, 1976.
41.
Mayeux R, Stern Y, Rosen J, Leventhal J. Depression, intellectual impairment and Parkinson's disease. Neurology 1981;31:645-650.
42.
Taylor AE, Saint-Cyr JA, Lang AE. Parkinson's disease and depression: a critical reevaluation. Brain 1986;109:279-292.
43.
Sano M, Stern Y, Williams J, Cote L, Rostenstein R, Mayeux R. Coexisting dementia and depression in Parkinson's disease. Arch Neurol 1989;46:1284-1286.
44.
Starkstein SE, Preziosi TJ, Bolduc PL, Robinson RG. Depression in Parkinson's disease. J Nerv Ment Dis 1990;178:27-31.
45.
Mayeux R. Parkinson's disease: a review of cognitive and psychiatric disorders. Neuropsychiatry Neuropsychol Behav Neurol 1990;3:3-14.
46.
Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry 1992;149:443-454.
47.
Troster AI, Paolo AM, Lyons KE, Glatt SL, Hubble JP, Koller WC. The influence of depression on cognition in Parkinson's disease: a pattern of impairment distinguishable from Alzheimer disease. Neurology 1995;45:672-676.
48.
Tison F, Dartigues JF, Auriacombe S, Letenneur L, Boller F, Alperovitch A. Dementia in Parkinson's disease: a population-based study in ambulatory and institutionalized individuals. Neurology 1995;45:705-708.
49.
Burn DJ, Sawle GV, Brooks DJ. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. J Neurol Neurosurg Psychiatry 1994;57:278-84.
50.
Blin J, Horwitz B, Baron J, Agid Y. Does frontal cortex hypometabolism in progressive supranuclear palsy result from subcortical dysfunction? Eur J Neurol 1995;1:221-228.
51.
Agid Y, Javoy-Agid F, Ruberg M, et al. Progressive supranuclear palsy: anatomoclinical and biochemical considerations. Adv Neurol 1987;45:191-206.
52.
Takahashi H, Oyanagi K, Takedo S, et al. Occurrence of 15-nm-wide straight tubules in neocortical neurons in progressive supranuclear palsy. Acta Neuropathol (Berl) 1989;79:233-239.
53.
Hauw J-J, Venry M, Delaere P, et al. Constant neurofibrillary changes in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging. Neurosci Lett 1990;119:182-186.
54.
Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-381.
55.
Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993;50:873-880.
56.
Jellinger KA, Bancher C. Neuropathology. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992;44-88.
57.
Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci USA 1987;84:5976-5980.
58.
Javoy-Agid F. Cholinergic and peptidergic systems in PSP. J Neural Transm Suppl 1994;42:205-218.
59.
Levy R, Ruberg M, Herrero MT, et al. Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA. Neurology 1995;45:127-134.
60.
Menza MA, Cocchiola J, Golbe LI. Psychiatric symptoms in progressive supranuclear palsy. Psychosomatics 1995;36:550-554.

Information & Authors

Information

Published In

Neurology®
Volume 47Number 5November 1996
Pages: 1184-1189
PubMed: 8909427

Publication History

Published online: November 1, 1996
Published in print: November 1996

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Jeffrey L. Cummings, MD
From the Neuroepidemiology Branch (Dr. Litvan), National Institutes of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; the Departments of Neurology (Drs. Mega, Cummings, and Fairbanks), and Psychiatry and Biobehavioral Science (Dr. Cummings), UCLA School of Medicine; and the Behavioral Neuroscience Section (Drs. Mega and Cummings), Psychiatry Service, West Los Angeles Veterans Affairs Medical Center, Los Angeles, CA.
Supported by the Department of Veteran Affairs, NIA Alzheimer Disease Center grant (AG10123) and the Irving and Helga Cooper Award of the UCLA Center on Aging.
Received February 16, 1996. Accepted in final form March 20, 1996.
Address correspondence and reprint requests to Dr. Irene Litvan, Neuroepidemiology Branch, NINDS, NIH, Federal Bldg., Room 714, Bethesda, MD 20892-9130.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. The Telencephalon, From Anatomy to Function of the Central Nervous System, (453-485), (2025).https://doi.org/10.1016/B978-0-12-822404-5.00021-8
    Crossref
  2. Movement disorders and cognition, Encyclopedia of the Human Brain, (589-614), (2025).https://doi.org/10.1016/B978-0-12-820480-1.00138-8
    Crossref
  3. Impulse Control Disorders in Parkinson’s Disease and Atypical Parkinsonian Syndromes—Is There a Difference?, Brain Sciences, 14, 2, (181), (2024).https://doi.org/10.3390/brainsci14020181
    Crossref
  4. Behavioral disinhibition in stroke, Frontiers in Neurology, 15, (2024).https://doi.org/10.3389/fneur.2024.1345756
    Crossref
  5. Zespół apatii w chorobach neurologicznych – stan wiedzy i aktualne kierunki badań, Przegląd Psychologiczny, 67, 1, (93-112), (2024).https://doi.org/10.31648/przegldpsychologiczny.9439
    Crossref
  6. SEND-PD in Parkinsonian Syndromes: Results of a Monocentric Cross-Sectional Study, Neuropsychiatric Disease and Treatment, Volume 20, (1849-1859), (2024).https://doi.org/10.2147/NDT.S474584
    Crossref
  7. Progressive supranuclear palsy, A Review on Diverse Neurological Disorders, (273-280), (2024).https://doi.org/10.1016/B978-0-323-95735-9.00022-X
    Crossref
  8. Progressive Supranuclear Palsy, Reference Module in Neuroscience and Biobehavioral Psychology, (2024).https://doi.org/10.1016/B978-0-323-95702-1.00141-X
    Crossref
  9. Progressive Supranuclear Palsy (PSP), Movement Disorders Phenomenology, (135-163), (2024).https://doi.org/10.1007/978-3-031-52573-5_4
    Crossref
  10. Late‐life mood disorder as the initial presentation of progressive supranuclear palsy: A case series, Psychiatry and Clinical Neurosciences Reports, 3, 1, (2024).https://doi.org/10.1002/pcn5.178
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share